Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF): Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), Amplia MRI. Labeled as the following: a. Amplia MRI CRT-D DF4 (Product No. DTMB1D4); b. Amplia MRI Quad CRT-D DF1 (Product No. DTMB1Q1); c. Amplia MRI Quad CRT-D DF4 (Product No. DTMB1QQ); EXPANSION: d. Amplia MRI CRT-D DF1 (Product No. DTMB1D1) Implantable devices that automatically detect and treat episodes of ventricular fibrillation, ventricular tachycardia, fast ventricular tachycardia, and bradyarrhythmia. Some devices can also provide resynchronization therapy, including sequential biventricular pacing (CRT-D devices).

Recall number

Z-0582-2018

Recalling firm

Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

Product

Cardiac Resynchronization Therapy Defibrillators (CRT-Ds), Amplia MRI. Labeled as the following: a. Amplia MRI CRT-D DF4 (Product No. DTMB1D4); b. Amplia MRI Quad CRT-D DF1 (Product No. DTMB1Q1); c. Amplia MRI Quad CRT-D DF4 (Product No. DTMB1QQ); EXPANSION: d. Amplia MRI CRT-D DF1 (Product No. DTMB1D1) Implantable devices that automatically detect and treat episodes of ventricular fibrillation, ventricular tachycardia, fast ventricular tachycardia, and bradyarrhythmia. Some devices can also provide resynchronization therapy, including sequential biventricular pacing (CRT-D devices).

Status

Terminated

Initiated

2017-12-19

Posted

2018-02-01

Terminated

2021-08-27

Reason

Possible prevention of high and low voltage therapy in Medtronic Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillator (CRT-D).

Root cause

Process design

Action

On 12/19/2017, Medtronic verbally notified consignees and retrieved eight devices at sites that had affected inventory on hand. On 01/22/2018, Medtronic provided a recall notification letter to physicians following 48 patients implanted with affected devices and risk managers of those medical facilities, recommending that physicians strongly consider prophylactic device replacement for patients implanted with an affected device. Medtronic Technical Services is available to assist physicians with questions at 800-723-4636. Medtronic Patient Service is available to assist patients at 800-551-5544 (Monday-Friday, 8am-5pm Central Time). The recall was expanded on 03/15/2018 and customers were notified by letter. Affected product, not yet implanted, was retrieved on about 03/08/2018. Instructions in the physicians following patients implanted with the additional affected devices included prophylactic device replacement for those patients at higher risk, including patients whose clinical history indicates prior need for high-voltage therapy and/or for pacemaker-dependent patients. The physicians should carefully weigh the risks and benefits of device replacement. If it is determined that replacement is not warranted, instructions included the following: programming changes to reduce the potential for high-voltage charges associated with arrhythmia detection and therapies, such as enabling ATP before charging for fast ventricular rhythms or programming a separate fast VT via VF zone with ATP; Continue three-month in-clinic or remote follow-ups to verify device functionality because inability to interrogate a device or a failed remote monitoring transmission may be an indication that internal arcing has occurred; and to advice patients to seek medical attention immediately if they experience new or unexpected symptoms suspicious for a ventricular arrhythmia. Medtronic Patient Services is available to assist patients at 800-551-5544 (Monday-Friday, 8am-5pm Centra

Quantity

951 devices total

Distribution

US Nationwide Distribution.

Lot, serial or model codes

a. Product No. DTMB1D4: UDI 00643169543430 (Serial No. RPJ201956H, RPJ202805H) (EXPANSION: Serial No. RPJ201660H, RPJ201661H, RPJ201972H, RPJ202145H, RPJ202821H, RPJ203208H, RPJ203209H, RPJ203826H);  b. Product No. DTMB1Q1: UDI 00643169705784 (Serial No. RPU201108H) (EXPANSION: Serial No. RPU201289H, RPU201290H, RPU201291H, RPU201292H, RPU201293H, RPU201295H, RPU201296H, RPU201297H, RPU201298H, RPU201299H, RPU201300H, RPU201301H, RPU201302H, RPU201303H, RPU201305H, RPU201306H, RPU201287H, RPU201288H, RPU201619H, RPU201621H, RPU201635H, RPU201304H);  c. Product No. DTMB1QQ: UDI 00643169929647 (Serial No. RPE219331H, RPE218183H), 00643169543386 (Serial No. RPE201417H, RPE204789H, RPE206207H, RPE207850H, RPE209095H, RPE212027H) (EXPANSION: Serial No. RPE215624H, RPE217014H, RPE200352H, RPE200394H, RPE201115H, RPE201328H, RPE202133H, RPE202941H, RPE203460H, RPE203771H, RPE203998H, RPE204209H, RPE204790H, RPE204791H, RPE204792H, RPE205432H, RPE206879H, RPE206886H, RPE208041H, RPE208241H, RPE208355H, RPE208369H, RPE208613H, RPE209037H, RPE209093H, RPE209135H, RPE209190H, RPE209194H, RPE209553H, RPE210227H, RPE210228H, RPE210672H, RPE210673H, RPE210734H, RPE210841H, RPE210844H, RPE210869H, RPE210870H, RPE210874H, RPE210875H, RPE211011H, RPE211012H, RPE211731H, RPE211732H, RPE211734H, RPE211736H, RPE211820H, RPE211858H, RPE211859H, RPE213564H, RPE214135H, RPE214544H, RPE214545H, RPE214546H, RPE215260H, RPE215628H, RPE216247H, RPE217013H, RPE217332H, RPE217335H, RPE217399H, RPE217443H, RPE217444H, RPE217446H, RPE217850H, RPE218146H, RPE218307H, RPE218308H, RPE219117H, RPE210877H, RPE215451H, RPE215625H, RPE215627H, RPE217445H, RPE217849H, RPE218148H, RPE215626H);   EXPANSION:  d. Product No. DTMB1D1: UDI 00643169705791 (Serial No. RPV200926H, RPV201075H, RPV201757H, RPV201758H)

510(k) numbers

not on file

PMA numbers

["P010031S513","P010031S550"]

Product code

NIK

Firm FEI

2182208

Firm city

Mounds View

Firm state

MN

Firm country

not on file

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Copy